One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-120737
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 35 |
Affiliation: Hôpital Claude Huriez, Genmab (United States), University of Southern Denmark, Vejle Sygehus, Janssen (Belgium), Karolinska University Hospital, Karolinska Institutet, Janssen (United States), The Royal Wolverhampton NHS Trust, Délégation Centre-Est, St Vincent's Hospital, University of Melbourne, Universitätsklinikum Tübingen, Florida Cancer Specialists & Research Institute, Levine Cancer Institute, National Center for Tumor Diseases, Heidelberg University, University Hospital Heidelberg, University of Alberta, Hôpital Cardiologique du Haut-Lévêque, The University of Texas MD Anderson Cancer Center, Ollscoil na Gaillimhe – University of Galway, Institute of Cancer Research, University of Calgary, Mayo ClinicPhase 3 Randomized Study of Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant (MAIA)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
